ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, has made significant strides of late with the launch of…
Read More »NASDAQ
The agreement adds two drug candidates to the company’s product pipeline, “EL-22”, a clinical-stage engineered probiotic expressing myostatin, and “EL-32”,…
Read More »
With the obesity drug market poised for exponential future growth, here’s the skinny on the top obesity and weight-loss stocks…
Read More »
The company also reported record Q4 2023 revenue of $698,591, up 403% over the previous quarter. Elevai Labs Inc. (NASDAQ:…
Read More »
The company’s Q4 top and bottom line figures represent a massive increase of 265% and 765% over last year’s fourth…
Read More »
Last Updated: Who were the winners and losers of last week’s big tech earnings season? Let’s take a look at…
Read More »
Elevai Labs (NASDAQ: ELAB), a medical aesthetic company specializing in physician-dispensed skincare, today announced the closing of its previously announced…
Read More »
Shares of Elevai Labs have been approved for listing on the NASDAQ and Will Commence Trading on November 21, 2023,…
Read More »
Last Updated: The Capitalist Countdown is a weekly series that features the biggest stories from the stock market’s hottest stocks as well…
Read More »
Last Updated: The Capitalist Countdown is a weekly series that features the biggest stories from the stock market’s hottest stocks as well…
Read More »